Literature DB >> 187613

Nonautonomous function of a pancreatic insulinoma.

E J Rayfield, M Pulini, A Golub, A H Rubenstein, D L Horwitz.   

Abstract

A 56-year-old woman with symptoms of weakness, visual blurring, and sweating underwent diagnostic studies to evaluate the etiology of her hypoglycemia. Fasting hypoglycemia was never documented; in diagnostic studies performed during her two hospitalizations and several outpatient glucose tolerance tests, the lowest fasting plasma glucose recorded was 56 mg/dl. The patient displayed exaggerated plasma insulin responses following oral glucose (peak response: 447 muU/ml at 30 min) and following 1 gm of iv tolbutamide (peak response: 719 muU/ml at 5 min) with symptomatic profound hypoglyceria during both tests. Basal per cent proinsulin was elevated at 49% (normal range 5-22%). Throughout a 72 h fast, values for plasma glucose, insulin, and glucose/insulin ratios were all within the normal range. During the infusion of exogenous insulin (0.1 U/kg for 60 min) serum C-peptide reactivity suppressed to less than 1.3 ng/ml when the plasma glucose fell below 40 mg/dl representing normal suppression. At surgery, a pancreatic beta cell adenoma was found and removed. This patient represents the uncommon circumstances in which stimulation tests with tolbutamide and glucose were more helpful in establishing a preoperative diagnosis than were the suppression tests.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 187613     DOI: 10.1210/jcem-43-6-1307

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas.

Authors:  R C Turner; L G Heding
Journal:  Diabetologia       Date:  1977-12       Impact factor: 10.122

2.  The value of artificial beta cell in the management of insulinoma.

Authors:  L J Valenta; H Eisenberg; D R Miller; S M Tanner; S G Romansky; A H Rubenstein; M Mako; B F Cullen; M P Golden; A N Elias
Journal:  West J Med       Date:  1982-07

3.  [The C-peptide suppression test in normal persons and insulinoma patients: an attempt to evaluate its use in functional diagnosis (author's transl)].

Authors:  H Mandelkow; K Goetz; J Kühnau
Journal:  Klin Wochenschr       Date:  1981-11-02

4.  Glucose-responsive Insulinoma with Insulin Hypersecretion Suppressed by Metformin.

Authors:  Kunihisa Hamano; Kayo Akita; Yoko Takeuchi; Tetsuya Suwa; Jun Takeda; Shuji Dodo
Journal:  Intern Med       Date:  2019-08-28       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.